Literature DB >> 6204672

Percutaneous penetration in the hairless dog, weanling pig and grafted athymic nude mouse: evaluation of models for predicting skin penetration in man.

W G Reifenrath, E M Chellquist, E A Shipwash, W W Jederberg, G G Krueger.   

Abstract

The human skin grafted congenitally athymic (nude) mouse, pig skin grafted nude mouse, hairless dog, and weanling Yorkshire pig were evaluated as models for predicting skin penetration in man. Nine radiolabelled compounds previously tested on man were applied topically (4 micrograms/cm2) to each model. These compounds included caffeine, benzoic acid, N, N-diethyl-m-toluamide, three steroids, and three insecticides. To correct for incomplete excretion of the label following topical absorption, per cent penetration was calculated by dividing the per cent of the topically applied radioactive dose recovered in the excreta by the corresponding percentage after parenteral administration and multiplication by 100. Calculated values of per cent penetration were confirmed in the case of the grafted nude mouse because significant correlations (r = 0.78 for human skin grafted athymic nude mouse and r = 0.97 for pig skin grafted athymic nude mouse) were found between the calculated values and the actual values obtained by summing the radioactivity recovered in the urine, faeces, tissues, and carcass. The results also revealed a significant correlation between human skin grafted athymic nude mouse values and human values (r = 0.74, P = 0.05) and between weanling Yorkshire pig values and human values (r = 0.83, P = 0.05). In contrast, no significant correlation existed between human values and those of the hairless dog and the pig skin grafted athymic nude mouse.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204672     DOI: 10.1111/j.1365-2133.1984.tb15590.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  The bioavailability of dermatological and other topically administered drugs.

Authors:  R H Guy; A H Guy; H I Maibach; V P Shah
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

2.  Dermal injection of immunocytes induces psoriasis.

Authors:  T Wrone-Smith; B J Nickoloff
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

3.  Disparity of in vitro and in vivo oleic acid-enhanced beta-estradiol percutaneous absorption across human skin.

Authors:  L K Pershing; G E Parry; L D Lambert
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

4.  Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules.

Authors:  Grace Tan; Peng Xu; Louise B Lawson; Jibao He; Lucia C Freytag; John D Clements; Vijay T John
Journal:  J Pharm Sci       Date:  2010-02       Impact factor: 3.534

5.  Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing.

Authors:  Andreas Kurtz; Achim Aigner; Rafael H Cabal-Manzano; Robert E Butler; Dozier R Hood; Roy B Sessions; Frank Czubayko; Anton Wellstein
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

6.  Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice.

Authors:  Sarah-Jane Cozzi; Thuy T Le; Steven M Ogbourne; Cini James; Andreas Suhrbier
Journal:  Arch Dermatol Res       Date:  2012-08-08       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.